So this is sort of like again what we talked about by having this amount of data that is available and that is easily accessible any type of real-world research can be done very easily and this is where we think that we will we would allow a faster pace of progress in terms of developing new targets, in terms of assessing new biomarkers, once again in a real-world setting, without compromising patients’ privacy...
So this is sort of like again what we talked about by having this amount of data that is available and that is easily accessible any type of real-world research can be done very easily and this is where we think that we will we would allow a faster pace of progress in terms of developing new targets, in terms of assessing new biomarkers, once again in a real-world setting, without compromising patients’ privacy.
This transcript is AI-generated. While we strive for accuracy, please verify this copy with the video.
